Medical Cannabis for Spinal Cord Injury: A Complete Patient Resource Guide

Living with a spinal cord injury can mean managing nerve pain, muscle spasms, sleep problems, and changes in daily independence at the same time. Medical cannabis treatment may help some patients manage selected symptoms, but the best approach depends on your injury, medications, blood pressure, routines, and goals.  This guide explains what cannabis may offer, where its limits matter, and how to plan a careful trial with your care team while protecting rehabilitation, safety, and long-term function in everyday life.

1. How to Use This Patient Guide

1.1 What this guide will help patients decide

This guide helps you decide whether one or more spinal cord injury symptoms could be reasonable targets for a medically supervised cannabis trial. It walks you through the evidence, product choices, routes, THC and CBD content, possible interactions, daily safety concerns, costs, and legal limits that may affect your decision. Begin by choosing the changes that would matter most in your life. Your main goal might be:

• Less burning, shooting, electric, or tingling nerve pain
• Fewer painful spasms or less disruptive nighttime clonus
• Longer sleep with fewer awakenings from pain or muscle activity
• Greater comfort during transfers, wheelchair use, exercise, or therapy
• Better participation in work, social activities, or personal care

These goals give you something concrete to measure. A temporary feeling of calm, sleepiness, or intoxication does not prove by itself that cannabis is helping your spinal cord injury symptoms.

1.2 What medical cannabis can and cannot do

Medical cannabis may help some people manage symptoms such as neuropathic pain, troublesome spasms, sleep disruption, nausea, or poor appetite. Results vary because injury level, injury completeness, previous cannabis exposure, other medicines, blood pressure, breathing, metabolism, and symptom triggers can all shape your response. Cannabis cannot repair the spinal cord, restore damaged nerve pathways, or guarantee the return of movement or sensation. It should not replace rehabilitation, bladder and bowel care, pressure relief, mobility training, prescribed medicines, or assessment of new complications. The most useful question is not simply whether cannabis makes you feel different. Ask whether it helps you sleep, transfer, sit, exercise, work, or complete care routines with acceptable side effects. Meaningful improvement should support your function rather than hide a problem that needs medical attention. New or worsening pain, spasms, weakness, bladder changes, bowel changes, breathing problems, or skin concerns should still be assessed, even when cannabis temporarily makes the symptoms feel less intense.

1.3 Important limitations and medical disclaimer

Use this guide to prepare for conversations with your spinal cord injury physician, rehabilitation specialist, primary care clinician, pharmacist, and therapists. They can review your medicines, usual blood pressure, breathing, mental health, transfer safety, and treatment goals before you begin. Do not suddenly stop baclofen, opioids, gabapentin, pregabalin, antidepressants, bladder medicines, or other prescriptions because cannabis appears helpful. Some medicines require gradual changes and close monitoring to prevent withdrawal, stronger symptoms, or other complications. Cannabis products, labels, medical program rules, and legal protections differ by location. Recheck local requirements before buying, carrying, driving with, or traveling with cannabis. Schedule regular reviews so you continue only when the benefits remain clear, the side effects remain manageable, and the plan still supports your spinal cord injury care. A safe medical cannabis plan should help you participate more fully in daily life without interfering with rehabilitation, personal care, judgment, or independence.

2. Understanding Spinal Cord Injury Before Considering Cannabis 

2.1 Injury level and completeness

Your injury level indicates the lowest level of the spinal cord where normal movement and sensation remain. Cervical injuries may affect the arms, hands, trunk, legs, and breathing, while thoracic, lumbar, and sacral injuries usually affect progressively lower parts of the body. An incomplete injury allows some nerve messages to pass below the injury. A complete injury means normal nerve communication is absent below the injury according to neurological testing. Your AIS classification may provide a more detailed description of preserved movement and sensation. According to a 2026 review from the National Institute of Neurological Disorders and Stroke, the effects of SCI depend on the injury’s location and severity, while an incomplete injury preserves some communication below the damaged area. Injury level and completeness help predict your needs, but they do not tell the whole story. Two patients with similar classifications may have different pain, spasms, blood pressure patterns, breathing ability, hand function, and medication responses, so your cannabis plan must be based on your own symptoms.

2.2 Primary injury versus secondary health conditions

The primary injury is the original damage to your spinal cord and nearby tissues. This damage may cause immediate changes in movement, sensation, strength, breathing, bladder function, bowel control, and sexual function. Secondary health conditions develop because of the injury or the changes it creates in your body. Common examples include neuropathic pain, spasticity, pressure injuries, urinary infections, constipation, breathing problems, unstable blood pressure, and autonomic dysreflexia. Cannabis may make pain, spasms, nausea, or sleep problems feel more manageable, but it cannot correct every underlying cause. New pain, stronger spasms, bladder changes, bowel problems, skin damage, breathing difficulty, or sudden weakness should be medically assessed instead of treated only with a larger cannabis dose.

2.3 Creating a personal SCI symptom map

A personal symptom map records how your spinal cord injury affects your body and daily routine. It gives you a baseline that can later show whether cannabis helps a specific problem rather than simply causing relaxation or sleepiness. Include the following details:

• Your injury level and AIS classification
• Areas with reduced, absent, or altered sensation
• The location and type of your pain
• Your usual spasm pattern and common triggers
• Your normal bladder and bowel routines
• Your usual blood pressure range
• Your risk of autonomic dysreflexia
• Activities limited by pain, spasms, or poor sleep

Update the map when your health, medicines, equipment, or daily function changes. Record whether each symptom occurs above, at, or below your injury level, since burning pain below the injury may require a different approach from shoulder pain caused by wheelchair use.

3. Medical Cannabis Fundamentals for People With SCI 

3.1 Cannabis, medical cannabis, and cannabinoid medicines

Cannabis is a plant containing active compounds called cannabinoids. THC can cause intoxication and changes in thinking or coordination, while CBD does not normally produce the same high when used by itself. Medical cannabis refers to cannabis used with the goal of managing a health symptom. The term "medical" describes the purpose of use, but it does not guarantee that every oil, edible, flower, vape, or topical product has proven effectiveness or consistent quality. A 2023 overview from the U.S. Food and Drug Administration states that approved cannabinoid medicines are specific prescription products reviewed for safety, effectiveness, and quality, unlike unapproved cannabis products available to consumers. Cannabinoid medicines are regulated prescription drugs containing purified or synthetic cannabinoids. FDA-approved examples include cannabidiol for certain seizure disorders and synthetic cannabinoid medicines for chemotherapy-related nausea or appetite loss associated with AIDS. These medicines are different from dispensary products.

3.2 How cannabinoids affect the nervous system

THC and CBD affect the nervous system in different ways. The result you feel can depend on the amount of THC, the product type, your previous cannabis experience, other substances you use, and your individual biology. THC may change pain perception, mood, movement, time perception, attention, memory, coordination, and reaction time. These effects may help some patients feel less distressed by symptoms, but they can also interfere with transfers, wheelchair control, medication routines, and other tasks requiring clear judgment. CBD usually does not cause the same intoxicating effect, but it is still an active substance. It may cause side effects or interact with medicines, and it should not be assumed to repair damaged spinal cord pathways. Your response should be measured through symptom relief, safety, and daily function.

3.3 FDA approval versus state-authorized access

FDA approval means a specific medicine has been reviewed for its ingredients, manufacturing quality, safety, effectiveness, dose, and intended medical use. The FDA has not approved the cannabis plant or dispensary cannabis products as treatments for spinal cord injury. State-authorized access is different. A state program may permit you to obtain medical cannabis after a clinician confirms that you meet its requirements, but that authorization does not make each dispensary product an FDA-approved medicine. This distinction helps you set realistic expectations. Your medical cannabis card may provide legal access under state rules, while you and your care team must still evaluate the product, dose, route, benefits, side effects, and interactions carefully.

4. What the Research Actually Shows in Spinal Cord Injury

4.1 Evidence for SCI-related neuropathic pain

Research suggests that THC-containing cannabis may reduce neuropathic pain for some people with spinal cord injury. Small controlled studies have reported temporary pain reductions after inhaled cannabis, but the studies involved limited numbers of participants and measured effects over short periods. Broader reviews of cannabis based medicines for neuropathic pain have found that some patients may achieve useful relief. However, the average benefit is usually modest, and dizziness, sleepiness, confusion, and other side effects may limit treatment for some patients. According to a 2021 clinical practice guideline by Busse et al., noninhaled medical cannabis and cannabinoids may provide improvements in chronic pain and sleep, although dizziness, drowsiness, and cognitive effects can occur. The findings support cannabis as a possible symptom management option rather than a proven first treatment for every patient. A careful trial may be reasonable when neuropathic pain remains disruptive despite established care, especially when you can track pain, function, sleep, and side effects.

4.2 Evidence for spasticity and spasms

Research on cannabis for SCI-related spasticity is much smaller than the research on neuropathic pain. Some patients report less stiffness, fewer spasms, or easier sleep, but patient reports do not always match changes measured during a physical examination. Much of the stronger cannabinoid research on spasticity comes from people with multiple sclerosis rather than spinal cord injury. These findings may help researchers understand possible effects, but they cannot prove that the same product will produce the same results after SCI. A 2022 Cochrane review by Filippini et al. found that nabiximols probably reduces patient-reported spasticity in people with multiple sclerosis in the short term, although evidence for several other outcomes remains uncertain. Cannabis may be considered when spasms remain painful, interrupt sleep, disturb positioning, or interfere with care. It should not automatically replace stretching, positioning, therapy, baclofen, tizanidine, injections, or an intrathecal pump when these treatments remain necessary.

4.3 Why the evidence remains uncertain

SCI cannabis studies often include small groups, brief treatment periods, and products that differ in THC content, CBD content, dose, and route. These differences make it difficult to compare results or identify one approach that works for most patients. Cannabis research also faces challenges with blinding because participants may recognize THC effects and guess whether they received the active product. Pain, spasm severity, sleep, and comfort are commonly measured through self-reports, which are important but can vary with expectations and daily health conditions. Long-term information is especially limited. Researchers still need stronger evidence on continued effectiveness, tolerability, dependence, medication reduction, cognition, blood pressure, breathing, and daily functioning in people with varying injury levels. Broader evidence reviews continue to describe cannabis benefits for chronic pain as generally small and product-dependent.

5. Cannabis for Neuropathic Pain After SCI

5.1 Recognizing neuropathic pain

Neuropathic pain develops when the spinal cord or the nerves connected to it send abnormal sensory signals. It may occur at the level of injury or below, including areas where normal touch or temperature sensation is reduced or absent. You may describe neuropathic pain as:

• Burning or intense heat
• Electric shocks or shooting sensations
• Pins and needles or tingling
• Stabbing, cutting, or squeezing pain
• Pain from light touch, clothing, or cool air
• Pain felt in an area with little normal sensation

Neuropathic pain is different from shoulder strain, joint pain, muscle soreness, abdominal discomfort, or pain caused by a pressure injury. Because several pain types can occur together after SCI, ask your clinician to help identify the main source before using cannabis as a targeted treatment.

5.2 When cannabis may be considered

Cannabis may be considered when confirmed neuropathic pain continues to disturb sleep, mood, concentration, therapy, work, transfers, or other daily activities. It may also be discussed when established medicines provide incomplete relief or cause side effects that make regular use difficult. This does not mean you must try every possible medicine before discussing cannabis. Your clinician can review treatments you have used, the doses you reached, how long you used them, the relief they provided, and why you stopped or continued them. Cannabis should usually be added to a coordinated pain plan rather than used as the entire plan. Medicines, movement, positioning, sleep care, psychological support, and treatment of pain triggers may still be needed even when cannabis provides some relief.

5.3 Measuring meaningful pain improvement

Meaningful improvement is not limited to a lower number on a pain scale. A useful response may mean that pain wakes you less often, interrupts fewer transfers, requires fewer recovery breaks, or feels less overwhelming during work and personal care. Record your pain before cannabis, after the expected onset, and again when the effects should be wearing off. Use the same scale and record the product, THC amount, CBD amount, route, time taken, sleep quality, alertness, and any unwanted effects. Continue only when the overall benefit is clear. A small pain reduction may still matter if you sleep or function better, but strong intoxication without better function is not a successful medical result. Reassess the plan if relief fades quickly or if side effects compromise safety.

6. Cannabis for Spasticity, Muscle Tightness, and Spasms

6.1 Understanding spasticity after SCI

Spasticity occurs when disrupted nerve signaling causes muscles to tighten, stiffen, jerk, or contract involuntarily. You may experience constant tightness, sudden spasms, clonus, or stronger muscle reactions to movement and touch. Spasms may increase because of a full bladder, constipation, urinary infection, pressure injury, tight clothing, pain, skin irritation, temperature changes, or poor positioning. A sudden change in your usual pattern may signal a health problem that needs assessment. Cannabis may help some patients feel less tight or less disturbed by spasms, but relief should be measured through sleep, positioning, transfers, personal care, and comfort. Feeling heavily sedated is not the same as gaining useful spasticity control.

6.2 Helpful versus harmful spasticity

Spasticity is not always harmful. Some muscle tone may help you stand, transfer, maintain posture, grip an object, or preserve muscle mass, so removing every spasm may reduce function rather than improve it. Spasticity may need treatment when it causes:

• Pain or repeated sleep interruption
• Unsafe transfers or wheelchair positioning
• Difficulty with catheterization or personal care
• Skin rubbing or pressure injury risk
• Loss of joint movement
• Breathing or bladder problems

Before using cannabis, identify which spasms help and which interfere with your life. Your goal may be fewer painful nighttime spasms while keeping enough tone for transfers, standing, dressing, or other activities.

6.3 Comparing cannabis with established treatments

Established spasticity care may include stretching, range-of-motion exercises, positioning, braces, standing, cycling, electrical stimulation, and treatment of triggers. Medicines may include baclofen, tizanidine, dantrolene, benzodiazepines, botulinum toxin injections, or an intrathecal baclofen pump. Cannabis is generally considered an additional symptom option rather than a replacement for these treatments. Evidence specific to SCI remains limited, and cannabis may also cause dizziness, sleepiness, poor coordination, confusion, or low blood pressure. According to a 2023 spinal cord injury factsheet by Reyes and Chiodo, spasticity management may require a combination of physical treatments, oral medications, injections, or intrathecal baclofen, selected based on the patient’s goals and potential side effects. Compare treatments by how they affect your real goals. The best plan may combine therapy, trigger control, an established medicine, and carefully selected cannabis rather than relying on one product to manage every type of muscle activity.

7. Other SCI Symptoms Patients Commonly Hope Cannabis Will Improve

7.1 Sleep disruption

SCI can disturb sleep through neuropathic pain, spasms, bladder routines, bowel discomfort, temperature changes, positioning needs, breathing problems, and nighttime personal care. Repeated spasms alone can interrupt sleep and contribute to daytime tiredness. Cannabis may help some patients fall asleep by reducing pain distress, muscle activity, or difficulty relaxing. It does not treat causes such as sleep apnea, reduced nighttime breathing, a blocked catheter, infection, or uncontrolled bowel problems. Judge a nighttime product by how you function the next morning. Track awakenings, total sleep, pain, spasms, alertness, transfers, blood pressure symptoms, and whether you complete your morning care safely.

7.2 Mood, anxiety, and adjustment

Sadness, grief, frustration, and emotional adjustment can occur after SCI, but they are not always the same as major depression. Persistent low mood, loss of interest, poor concentration, major sleep changes, or hopelessness may require professional care. Cannabis may help you feel calmer for a short period, especially when pain or spasms create distress. It should not replace counseling or prescribed mental health treatment, and THC can cause anxiety, paranoia, or disorientation in some people. Tell your clinician if cannabis worsens panic, low mood, motivation, confusion, or social withdrawal. Seek urgent help for thoughts of self-harm, severe agitation, hallucinations, or feeling unable to remain safe.

7.3 Appetite, nausea, fatigue, and general well-being

THC may increase appetite or reduce nausea for some patients, but evidence from approved cannabinoid medicines mainly involves chemotherapy-related nausea and appetite loss associated with AIDS. This does not prove that dispensary cannabis treats unexplained appetite or nausea problems after SCI. Poor appetite, nausea, or fatigue may come from constipation, infection, dehydration, pain, medication effects, sleep loss, depression, or another health condition. Cannabis should not delay evaluation when symptoms are new, severe, or accompanied by vomiting, fever, abdominal swelling, or bowel changes. Track meals, fluids, nausea, bowel activity, energy, sleep, and cannabis timing. A useful result should help you eat, rest, and participate in daily care without causing stronger fatigue, confusion, or reduced independence.

8. Autonomic Dysreflexia and Blood Pressure Safety

8.1 Who is at risk

Autonomic dysreflexia, often called AD, is a sudden and potentially dangerous rise in blood pressure caused by irritation below your injury level. It most often affects people with injuries at or above T6, although it can occur with lower injuries in rare cases. Common triggers include a full bladder, blocked catheter, constipation, skin injury, tight clothing, broken bone, or sexual activity. You may not feel the trigger because sensation below your injury level may be reduced or absent. Cannabis does not prevent or treat the cause of AD. If you are at risk, know your normal blood pressure, keep a working monitor nearby, and follow the emergency plan provided by your SCI team.

8.2 Distinguishing cannabis effects from autonomic dysreflexia

THC may cause a faster heartbeat, altered awareness, anxiety, flushing, or changes in blood pressure. Some of these effects can resemble parts of an AD episode, so symptoms alone may not tell you what is happening. Possible AD signs include:

• A pounding or sudden headache
• Sweating or flushing above the injury level
• Goose bumps or clammy skin
• Blurred vision or nasal congestion
• Restlessness with a blood pressure rise

A 2025 StatPearls review by Badur et al. defines autonomic dysreflexia in adults as a rise in systolic blood pressure of at least 20 mm Hg above the person’s usual baseline. Check your blood pressure whenever AD is possible, even if symptoms began after cannabis. A rise of about 20 to 40 points in systolic pressure above your usual baseline may indicate AD, and the episode will continue until the trigger is corrected.

8.3 Low blood pressure, transfers, and fainting

Some people with SCI have a resting blood pressure lower than the general population, particularly after higher injuries. Moving upright may also cause lightheadedness, weakness, blurred vision, or fainting when your body cannot adjust to the change in blood pressure quickly enough. Cannabis can affect heart rate, blood pressure, coordination, and alertness. During a first dose or dose increase, remain seated or supported and avoid attempting an unfamiliar transfer until you know how the product affects you. Stop the activity if you feel faint, unusually weak, confused, or unable to maintain balance. Check your blood pressure when possible and review repeated symptoms with your clinician, especially if you also use blood pressure medicines, muscle relaxers, opioids, or other sedating drugs.

9. Bladder, Bowel, and Sexual Health

9.1 Neurogenic bladder considerations

SCI can interrupt communication between your brain, bladder, and urinary sphincter. This may cause retention, leakage, an overactive bladder, or high bladder pressure that can contribute to infections, stones, kidney problems, and AD. Cannabis may reduce pain, spasms, nausea, or distress related to bladder care, but it does not empty the bladder or correct a blocked catheter. Sedation or altered time perception may also make it easier to miss catheterization, drainage, or medication schedules. Keep your established bladder program unchanged unless your urology or rehabilitation team adjusts it. Seek medical advice for new leakage, reduced urine flow, blood in the urine, fever, stronger spasms, cloudy urine, or other symptoms, or repeated AD episodes.

9.2 Neurogenic bowel considerations

Neurogenic bowel may cause constipation, stool leakage, abdominal discomfort, or difficulty completing bowel care. A consistent bowel program can support planned emptying and reduce complications such as pain, stronger spasticity, and autonomic dysreflexia. Cannabis may make cramping, nausea, or bowel distress feel less intense, but it can also change appetite, alertness, and daily routines. Strong sedation may make it harder to safely complete digital stimulation, medication timing, transfers, cleanup, or skin checks. Do not respond to constipation by taking more cannabis instead of following your bowel plan. Contact your care team for persistent abdominal swelling, vomiting, severe pain, repeated accidents, inability to pass stool, or a major change from your usual pattern.

9.3 Sexual function and intimacy

SCI may change genital sensation, erection, ejaculation, lubrication, orgasm, positioning, and muscle control. These changes do not remove your ability to experience intimacy or sexual satisfaction, but you may need different stimulation, communication, positioning, or medical support. Cannabis may reduce pain, spasticity, or anxiety for some patients, but too much THC may interfere with coordination, judgment, communication, or consent. Sexual activity can also trigger AD in people with injuries at or above T6. Plan cannabis use around comfort and safety rather than intoxication. Discuss persistent sexual concerns with an SCI clinician, urologist, gynecologist, fertility specialist, or sexual health therapist, especially when you experience pain, skin irritation, catheter problems, or AD symptoms.

10. Respiratory Health and High-Level SCI

10.1 Why respiratory function matters in SCI

A high cervical spinal cord injury can weaken the diaphragm, chest muscles, and abdominal muscles and impair coughing. Injuries involving C1 through C4 may require temporary or permanent breathing assistance because these spinal cord areas help control the diaphragm. A weak cough can make it harder to clear mucus from your lungs. This may increase your risk of airway blockage, lung infection, and pneumonia, especially if you use a ventilator or have trouble swallowing. Before using cannabis, tell your clinician about breathing weakness, sleep apnea, lung disease, assisted coughing, suctioning, oxygen, or ventilator use. A product that causes heavy sleepiness may make it harder to notice breathing changes or complete your usual respiratory care.

10.2 Smoking and vaping considerations

Smoking cannabis exposes your lungs to smoke, irritants, and toxic substances. Cannabis smoke can damage lung tissue and may contribute to coughing, mucus production, and bronchitis, which is important when SCI already limits your ability to clear secretions. Avoid or use added caution with inhaled cannabis if you have:

• A weak or ineffective cough
• Frequent mucus buildup
• Previous pneumonia
• Asthma or chronic lung disease
• Sleep-related breathing problems
• A tracheostomy or ventilator
• Trouble swallowing or aspiration risk

Vaping avoids burning plant material, but it does not remove all respiratory concerns. Concentrated THC oils may contain additives or contaminants, so inhaled products should come only from a regulated source and should be reviewed with your SCI clinician.

10.3 Noninhaled alternatives

Noninhaled options include oils, tinctures, capsules, tablets, edibles, beverages, and some products absorbed through the mouth. These routes avoid cannabis smoke, which may make them more suitable when breathing strength or cough function is reduced. Oral products usually take longer to work and may last longer than inhaled cannabis. Their effects can also be less predictable, so taking another dose too soon may cause strong intoxication, dizziness, confusion, or next-day sleepiness. A 2024 guidance from Health Canada states that cannabis that is eaten or drunk may take 30 minutes to two hours to produce effects and can continue affecting a person for up to 24 hours. Choose a route that you can measure and use safely. Consider whether you can open the package, measure the dose, swallow safely, remember the time taken, and wait long enough before deciding whether another dose is needed.

11. THC, CBD, Ratios, and Cannabis Terminology

11.1 THC: potential benefits and limitations

THC is the cannabinoid mainly responsible for the intoxicating effects of cannabis. It may help some SCI patients manage neuropathic pain, painful spasms, poor sleep, nausea, appetite loss, or distress related to persistent symptoms. THC may also affect memory, attention, judgment, coordination, reaction time, heart rate, and blood pressure. These effects may interfere with wheelchair control, transfers, catheterization, bowel care, medication timing, work, or driving. More THC does not always mean better symptom relief. Your goal is to find an amount that supports comfort or function without causing anxiety, confusion, unsafe movement, heavy sedation, or difficulty completing daily care.

11.2 CBD: what patients should realistically expect

CBD is an active cannabinoid that does not normally cause the same high as THC when used by itself. Some patients consider it when they want symptom support with less risk of intoxication, but evidence does not show that ordinary CBD products repair spinal cord damage. CBD may cause drowsiness, digestive changes, appetite changes, or mood changes. It can also affect how certain medicines work, which matters if you take pain medicines, muscle relaxers, antidepressants, seizure medicines, blood thinners, or other prescriptions. Product quality and CBD amounts may differ from what the label claims. Choose a tested product, record the amount taken, and judge it by changes in pain, spasms, sleep, and function rather than assuming that a larger dose will work better.

11.3 Ratios, minor cannabinoids, and terpenes

A cannabis ratio compares the amount of CBD with the amount of THC. A product labeled 1:1 contains similar amounts of each cannabinoid, while a ratio such as 10:1 contains much more CBD than THC. Ratios help you compare products, but they do not predict exactly how you will feel. Your response also depends on the total amount taken, route, timing, previous cannabis use, medicines, biology, and sensitivity to THC. Labels may also mention minor cannabinoids such as CBG, CBN, or CBC and aromatic compounds called terpenes. These details may help identify products, but you should not rely on strain names or terpene claims without checking the measured THC and CBD amounts, dose, testing, and your own recorded response.

12. Comparing Routes of Administration

12.1 Inhaled products

Inhaled cannabis includes smoked flower, vaporized flower, and cannabis oil used in a vape device. Effects are usually noticed sooner than with swallowed products, which may help you judge whether a small amount changes sudden pain or spasms. Smoking exposes your lungs to irritants and many of the same harmful substances found in tobacco smoke. This route may be especially unsuitable if your SCI has weakened your breathing muscles, cough, or ability to clear mucus. Vaping avoids smoke from burning cannabis, but it does not remove every risk. Concentrated oils may contain high THC levels, additives, or contaminants, so use only regulated products and stop if you develop coughing, chest discomfort, or breathing changes.

12.2 Oral and edible products

Oral products include capsules, tablets, oils, gummies, baked foods, and cannabis infused drinks. They avoid inhaled smoke and may provide longer symptom coverage for nighttime pain, spasms, or repeated waking. Their effects can be delayed and less predictable than inhaled cannabis. The CDC notes that edibles and products with high THC concentrations may have delayed or unpredictable effects, which can increase the risk of taking too much. Take one measured amount and record the time before considering more. Make sure you can open the package, identify one serving, swallow it safely, and store the product out of reach of children, pets, caregivers, and visitors who might mistake it for ordinary food.

12.3 Oromucosal and topical products

Oromucosal products are placed under the tongue or against the inside of the cheek. Some of the cannabinoids may be absorbed through the mouth, while the portion you swallow may act more like an oral product. These products can be easier to measure than flower, but droppers and sprays still require accurate hand control or assistance. Hold the product as directed and avoid repeating the dose simply because the full effect has not appeared immediately. Topical creams, balms, and lotions are applied to the skin for localized discomfort. They should not be placed on pressure injuries, broken skin, irritated areas, or tissue you cannot inspect properly, and the FDA notes that important questions remain about how much CBD is absorbed through topical products.

13. How to Select a Reliable Cannabis Product

13.1 Reading the label correctly

Start by finding the THC and CBD amounts in one dose, not only the amount in the entire package. A container may hold several servings, so confusing the total amount with one serving can lead to a much larger dose than you intended. Check the product type, recommended serving, ingredient list, batch number, expiration date, storage directions, and required warning statements. For oils and tinctures, confirm how many milligrams are present in each milliliter or marked dropper amount. Do not rely on strain names, package colors, or words such as calming, medical, natural, or therapeutic. The FDA warns that some CBD products are sold with unproven claims and may not contain the cannabinoid amounts stated by the seller.

13.2 Product testing and certificates of analysis

A certificate of analysis is a laboratory report connected to a specific product batch. The batch number on the report should match the number printed on your package, and the report should come from a laboratory recognized under your state program. Review the report for:

• Measured THC and CBD potency
• Pesticide results
• Heavy metal results
• Residual solvent results
• Mold and microbial results
• The testing date and laboratory name
• Clear pass or fail findings

Testing requirements vary by state, so a certificate does not make every product identical or risk-free. Still, it gives you more useful information than marketing alone, especially because the FDA has found cannabinoid products with inaccurate CBD amounts and possible contamination involving pesticides, heavy metals, or THC.

13.3 Products to avoid or approach cautiously

Avoid products with no clear THC or CBD amount, no batch information, no available testing report, or no connection to a regulated seller. Homemade edibles and unlabeled oils are difficult to dose because you cannot confirm how evenly cannabinoids were distributed. Approach high THC concentrates, dabs, and very strong vape oils cautiously. The CDC notes that concentrates may contain high THC levels and may also contain additives or contaminants that could be harmful. Be cautious with products promising to repair the spinal cord, restore movement, cure neuropathic pain, or replace established SCI care. Unproven claims can delay proper diagnosis and treatment, which is one reason the FDA advises patients to discuss cannabis products with a healthcare professional.

14. Is Medical Cannabis Appropriate for Me?

14.1 Symptoms and treatment history

Medical cannabis may be worth discussing when a specific SCI symptom continues to affect sleep, therapy, transfers, work, personal care, or quality of life. The clearest treatment targets are usually neuropathic pain, painful spasms, repeated sleep interruption, nausea, or appetite problems rather than a general desire to feel better. Review what you have already tried, including medicines, therapy, stretching, positioning, equipment changes, injections, counseling, and sleep care. Record how long you used each treatment, the dose reached, the relief provided, and any side effects that limited continued use. You do not necessarily need to exhaust every treatment before discussing cannabis. However, your care team should confirm that the symptom has been correctly identified and that a treatable cause, such as infection, constipation, catheter blockage, skin damage, or poor positioning, is not being missed.

14.2 Health conditions requiring added caution

Cannabis may require added planning if you have low blood pressure, an irregular heart rhythm, heart disease, breathing weakness, liver disease, swallowing problems, or a history of fainting. THC can affect heart rate and blood pressure, while CBD may affect the liver and change how other medicines work. Extra caution is also appropriate if you have experienced severe anxiety, paranoia, hallucinations, psychosis, or another serious mental health condition. THC can cause disorientation, anxiety, or paranoia in some people, but this does not mean that every mental health diagnosis automatically prevents medical cannabis use. Tell your clinician about alcohol use and every prescription, nonprescription product, or supplement you take. Combining cannabis with opioids, sleep medicines, muscle relaxers, anxiety medicines, or other substances that reduce alertness may make sedation and daily SCI tasks harder to manage.

14.3 Practical ability to use cannabis safely

A product may be medically reasonable but still unsuitable if you cannot reliably measure, open, store, or take it. Consider your hand function, vision, swallowing ability, memory, medication routine, and whether you need assistance with droppers, packages, inhalers, or edible portions. You should also be able to wait for the expected onset before taking more. This is especially important with oral products because delayed effects can make it easy to repeat a dose before the first amount has fully taken effect. Plan where you will be during your first doses and who can assist if you become dizzy, confused, or unusually sleepy. Safe use may require a stable seated position, help with transfers, a blood pressure monitor, clearly labeled storage, and a written record of the dose and time.

15. Talking With the SCI Care Team

15.1 Which professionals should be involved

Your rehabilitation physician or SCI specialist can consider how cannabis may affect pain, spasticity, blood pressure, breathing, bladder care, bowel care, and overall function. SCI rehabilitation commonly involves a coordinated team because the injury can affect several body systems and areas of daily life. A pharmacist can review potential drug interactions and overlapping side effects, such as dizziness, sleepiness, confusion, or low blood pressure. Your primary care clinician, pain specialist, neurologist, urologist, mental health clinician, or respiratory specialist may also need to participate depending on your symptoms and health history. Physical and occupational therapists can help you notice whether cannabis changes transfers, balance, wheelchair control, hand use, endurance, or personal care. NINDS describes SCI rehabilitation as a team process that may include rehabilitation doctors, nurses, therapists, psychologists, nutrition professionals, social workers, and other specialists.

15.2 Information patients should bring

Bring a complete list of your prescriptions, nonprescription medicines, vitamins, supplements, alcohol use, and current cannabis products. Include the dose, timing, reason for use, and any medicine you take only when symptoms become severe. Share your injury level, AIS classification if known, usual blood pressure, autonomic dysreflexia risk, breathing needs, bladder routine, bowel routine, mental health history, and previous cannabis experience. This information helps your clinician identify risks that may not be obvious from the symptom you want to treat. Also bring your symptom map and a short treatment history. Explain what improvement would matter most, such as sleeping longer, completing transfers with less pain, reducing painful nighttime spasms, or participating more comfortably in therapy.

15.3 Questions to ask before starting

Use your appointment to create a clear trial rather than leaving with only general permission to use cannabis. Helpful questions include:

• Which symptom should I target first?
• Could cannabis interact with any of my medicines?
• Should I avoid THC, CBD, or a particular route?
• What starting amount is reasonable for me?
• How long should I wait before changing the dose?
• Which side effects mean I should reduce or stop?
• How should I check my blood pressure?
• When should we review the results?

Ask how cannabis should fit around catheterization, bowel care, therapy, transfers, sleep, work, and driving. A suitable plan should protect these routines rather than make them harder to complete. Before leaving, agree on the product characteristics, starting time, symptom goal, monitoring method, and review date. FDA approval does not extend to ordinary dispensary cannabis products, so ongoing clinical review remains important when judging benefit, safety, and product quality.

16. Designing a Personal Cannabis Trial

16.1 Establishing a baseline

A baseline shows how your symptoms and daily function look before cannabis changes them. Record information for several typical days so one unusually good or bad day does not control your decision. Track the details most closely connected to your treatment goal. Use the same scales and questions each day.

• Pain intensity and pain type
• Spasm frequency and severity
• Number of sleep interruptions
• Ability to complete transfers
• Participation in therapy or exercise
• Bladder and bowel routine changes
• Alertness and concentration
• Usual blood pressure and dizziness
• Current medicines and their timing

Keep your usual medicines, therapy, sleep schedule, and care routines as stable as possible during this baseline period. This makes it easier to judge whether later changes are connected to cannabis rather than several treatments changing at once.

16.2 Choosing one primary goal

Choose one main symptom or functional problem for your first trial. A focused goal gives you a clearer answer than trying to treat pain, spasms, sleep, mood, appetite, and fatigue at the same time. Make the goal specific and measurable. You might aim to reduce painful nighttime spasms, sleep longer, complete transfers with less nerve pain, or tolerate therapy with fewer interruptions. Other symptoms may also improve, and you should record those changes. However, your decision to continue should be based primarily on whether the original goal can be achieved without unacceptable sedation, dizziness, confusion, or loss of function.

16.3 Setting the trial period and review point

Set a trial period with your clinician before you begin. The period should be long enough to test the selected product carefully but short enough to prevent months of use without a clear review. Agree on when you will check progress and what information you will bring. Oral products may require more patience because their effects can begin later and last longer than expected, while individual responses also vary with THC strength, route, other substances, and previous cannabis experience. Create stop rules before the first dose. End the trial or contact your clinician if you develop severe anxiety, fainting, repeated confusion, unsafe transfers, worsening breathing, major blood pressure changes, or no meaningful improvement after appropriate adjustment.

17. Starting Dose and Titration

17.1 “Start low, go slow” for SCI

Starting low means using a small measured amount rather than beginning with the dose used by another patient. Going slow means allowing enough time to judge benefits and side effects before increasing that amount. This approach is especially important when SCI affects blood pressure, balance, hand control, breathing, memory, or transfer safety. Cannabis can change attention, coordination, movement, reaction time, and time perception, so the first dose should be taken in a safe setting. Remain seated or properly supported and arrange help if transfers require assistance. Do not combine the first dose with alcohol, a new medicine, or another cannabis product because you may not know which substance caused the response.

17.2 THC and CBD titration

THC usually requires cautious adjustment because even a small increase may change intoxication, anxiety, coordination, heart rate, or blood pressure. Use a product with a clearly stated amount so you know how much THC you are adding. CBD does not usually produce the same high, but it should not be increased without careful consideration. The FDA warns that CBD may cause drowsiness, affect the liver, and change how other medicines work, particularly when it is combined with substances that reduce alertness. Change only one cannabinoid amount at a time and keep the route consistent while you assess the result. The correct dose is the lowest amount that provides useful symptom relief without interfering with transfers, therapy, bladder care, bowel care, work, or clear thinking.

17.3 Timing doses around SCI routines

Plan doses around the activities that require your best coordination and attention. These may include transfers, wheelchair use, driving, catheterization, bowel care, standing practice, therapy, work, skin checks, and respiratory treatments. A nighttime dose may be practical when pain or spasms disturb sleep, but check how you feel the next morning. Lingering effects may interfere with blood pressure control, transfers, medication timing, or the ability to complete personal care safely. Allow enough time for the selected route to work before taking more. Edible effects may take about 30 minutes to two hours to appear and may last longer than expected, so early repeat dosing can cause excessive intoxication or injury.

18. Cannabis and Common SCI Medications

18.1 Pain and spasticity medicines

Many people with SCI use baclofen, tizanidine, gabapentin, pregabalin, opioids, antidepressants, or sleep medicines. Cannabis may be added when these treatments provide incomplete relief, but several of them can cause sleepiness, dizziness, slower thinking, or reduced coordination. THC may add to these effects and make transfers, wheelchair use, standing, catheterization, or nighttime care less safe. CBD can also cause drowsiness and may change how some medicines are processed, which could increase side effects or reduce a medicine’s effectiveness. Do not stop baclofen, opioids, gabapentin, pregabalin, antidepressants, or other prescribed medicines suddenly. Ask your clinician or pharmacist whether doses should remain unchanged during your cannabis trial so you can identify which treatment is helping and avoid withdrawal or returning symptoms.

18.2 Bladder, bowel, heart, and blood pressure medicines

Bladder medicines may already cause dry mouth, constipation, blurred vision, or sleepiness. Bowel medicines can change stool frequency and urgency, while alpha blockers and blood pressure medicines may contribute to dizziness when you sit upright or transfer. Cannabis can affect alertness, heart rate, and blood pressure, so combining it with these medicines may make lightheadedness or weakness more noticeable. This deserves added attention if your SCI already causes low resting blood pressure, fainting, or unstable circulation. Keep your catheterization, bowel care, and blood pressure medicines on their usual schedules unless your clinician changes them. Record dizziness, bowel changes, urine changes, blood pressure readings, and the timing of cannabis so your care team can identify a possible connection.

18.3 Other important interactions

Tell your clinician about blood thinners, seizure medicines, antidepressants, anxiety medicines, sleep aids, allergy medicines, antibiotics, supplements, and alcohol. A complete list matters because cannabis products may contain both THC and CBD, and each compound can affect medicines differently. CBD can change the action of other drugs and may contribute to liver injury, particularly when combined with medicines that also affect the liver. Alcohol and medicines that slow brain activity can increase cannabis related sedation and drowsiness. Use one cannabis product at first and avoid adding alcohol or another sedating substance during dose changes. Contact your pharmacist when a prescription is started, stopped, or adjusted because a cannabis amount that was previously manageable may no longer produce the same response.

19. Expected Side Effects and How to Respond

19.1 Common manageable effects

Common cannabis effects may include dry mouth, increased appetite, red eyes, sleepiness, dizziness, slower thinking, altered time perception, or mild anxiety. CBD may also cause diarrhea, reduced appetite, irritability, or changes in alertness. Mild effects often improve when you reduce the amount, choose a product with less THC, or allow more time between doses. Remain seated if you feel dizzy, drink fluids as directed by your SCI care plan, and avoid transfers or personal care tasks until your coordination feels normal. Record the product, dose, route, time, symptom relief, and unwanted effects. A manageable side effect may be acceptable when the benefit is meaningful, but it should not repeatedly interfere with bladder care, bowel care, skin checks, therapy, work, or independence.

19.2 Signs the dose may be too high

A cannabis dose may be too high when you feel heavily sedated, confused, panicked, disoriented, or unable to control your movements safely. You may also notice a racing heartbeat, poor concentration, vomiting, unusual weakness, or difficulty staying awake. Stop taking more cannabis and move to a safe seated or lying position with assistance when needed. Edible effects may take up to two hours to appear and can last longer than expected, so repeating the dose early may intensify the reaction. Stay with a trusted adult if you cannot transfer or complete care safely. Once the effects have passed, review the dose with your clinician and restart only at a smaller amount or with a lower THC product.

19.3 Symptoms needing urgent evaluation

Some symptoms should not be assumed to be ordinary cannabis effects. Seek urgent medical advice or emergency care for:

• Trouble breathing or difficulty waking
• Fainting, chest pain, or a severe irregular heartbeat
• A seizure or severe persistent vomiting
• Hallucinations, extreme agitation, or unsafe behavior
• A sudden pounding headache with a major blood pressure rise
• New weakness, loss of function, or severe unexplained pain
• Signs of a blocked catheter, serious infection, or bowel obstruction

A pounding headache, sweating, flushing, anxiety, vision changes, or sudden high blood pressure may indicate autonomic dysreflexia, particularly with an injury at or above T6. This is a medical emergency that requires you to follow your AD plan and locate the trigger rather than waiting for the cannabis effects to pass. Call emergency services when breathing is impaired, the person cannot be awakened, or the situation feels immediately dangerous. For concerning cannabis exposure that is not an immediate emergency, the CDC advises contacting a healthcare professional or Poison Control.

20. Daily Life Safety With SCI

20.1 Transfers, wheelchair use, and fall prevention

Cannabis can affect coordination, balance, judgment, reaction time, and awareness of body position. These changes may make transfers, standing, wheelchair control, and reaching tasks less predictable, especially after your first dose or a THC increase. Take early doses while seated securely and arrange assistance if you normally need help with transfers. Lock wheelchair brakes, position equipment correctly, clear the floor, and avoid transferring while dizzy, heavily sleepy, confused, or unable to control your movements. Transfer methods should protect your shoulders, wrists, and skin while allowing you to clear nearby surfaces. Ask your therapist to review your technique if cannabis changes your strength, timing, muscle tone, pain, or ability to follow the usual transfer sequence.

20.2 Skin protection and routine self-care

Reduced sensation can prevent you from noticing pressure, heat, moisture, friction, or skin injury. Areas where bones lie close to the skin are particularly vulnerable when you remain in one position for a long period. Cannabis related sleepiness or altered time perception may cause you to delay pressure relief, repositioning, catheter care, or skin inspection. Set alarms as needed and keep your established pressure-relief schedule even when pain or discomfort feels less noticeable. Check your skin after transfers, prolonged sitting, sleep, bathing, and use of equipment. Contact your SCI team when redness does not fade, an area becomes swollen or warm, the skin opens, drainage appears, or unexplained spasms and autonomic dysreflexia suggest hidden irritation.

20.3 Driving and operating equipment

Do not drive when cannabis has affected your attention, coordination, judgment, reaction time, or perception. Driving under the influence of cannabis is dangerous and illegal, even when the product was purchased through a medical cannabis program. There is no single waiting period that guarantees you are ready to drive because impairment varies by dose, THC strength, route, previous use, medicines, and individual response. Oral products may also continue affecting you after the strongest sensation has passed. Avoid using lifts, power tools, cooking equipment, exercise machines, or other devices when your reactions or judgment feel different. Arrange transportation before dosing, and never combine cannabis with alcohol before driving because using both can increase impairment.

21. Tolerance, Dependence, Withdrawal, and Problematic Use

21.1 Recognizing tolerance

Tolerance means that an amount that once helped begins producing less effect after repeated use. You may notice shorter pain relief, weaker sleep support, or a desire to use more THC to produce the same physical or mental response. Do not automatically increase your dose when the benefit changes. Stronger symptoms may reflect an infection, constipation, skin injury, equipment problem, medication change, poor sleep, or progression of another health condition rather than cannabis tolerance. Frequent use and rising THC amounts can increase the risk of overconsumption and cannabis use disorder. Review your diary with your clinician before increasing the dose, switching products, or switching to a stronger concentration.

21.2 Signs cannabis may be causing more harm than benefit

Medical use becomes concerning when cannabis repeatedly interferes with health, relationships, responsibilities, or SCI care. The issue is not simply how often you use it, but whether use remains controlled and continues serving the treatment goal. Warning signs may include:

• Taking more cannabis than you planned
• Repeatedly increasing the THC amount
• Trying to reduce use but being unable to do so
• Strong cravings or constant thoughts about the next dose
• Missing bladder, bowel, skin, medicine, or therapy routines
• Continuing despite unsafe transfers or repeated confusion
• Using before driving or other risky activities
• Giving up important work, social, or rehabilitation activities

These signs deserve an honest discussion rather than shame or punishment. Cannabis use disorder is treatable, and early help may allow you to regain control before use causes greater problems with independence, health, or relationships.

21.3 Reducing or stopping safely

You may decide to reduce or stop because cannabis is no longer helping, costs too much, causes side effects, affects work, or interferes with daily care. Tell your clinician what you use, how often you use it, and how much THC and CBD the product contains. After regular use, stopping may temporarily affect sleep, mood, appetite, cravings, pain perception, or awareness of spasms. A planned reduction can help you and your clinician separate withdrawal-related discomfort from the return of the original SCI symptom. Keep your prescribed pain and spasticity medicines stable unless your clinician directs otherwise. Seek support if you repeatedly cannot reduce use, and obtain prompt help for severe depression, unsafe behavior, hallucinations, suicidal thoughts, or symptoms that prevent you from completing essential SCI care.

22. Special Health Situations

22.1 Pregnancy, breastfeeding, and fertility

Tell your clinician if you are pregnant, breastfeeding, planning a pregnancy, or trying to conceive. The FDA advises against THC, CBD, and marijuana use during pregnancy and breastfeeding, while the CDC notes that cannabis chemicals can pass to a developing baby and enter breast milk. Do not use cannabis to manage pregnancy-related nausea without medical guidance. Your obstetric clinician can look for dehydration, medication effects, or a pregnancy complication and discuss treatments with better established safety information. Research on cannabis and human fertility remains incomplete, so uncertainty should not be mistaken for safety. Discuss cannabis use with a fertility specialist when you or your partner are planning conception, especially if use is frequent or the product contains substantial THC or CBD.

22.2 Older adults and newly injured patients

Older adults may use several medicines and may already experience low blood pressure, reduced balance, memory changes, or slower medication clearance. These factors can make dizziness, confusion, sedation, and transfer problems more noticeable after cannabis. A newly injured patient may still be adjusting to changes in sensation, spasticity, bladder and bowel care, blood pressure, breathing needs, and rehabilitation. Starting several new treatments together can make it difficult to identify what caused an improvement or unwanted effect. Begin only after your team has identified the symptom and established a reasonably stable care routine. A smaller starting amount, closer supervision, and frequent review may help protect function while you learn how cannabis affects your changing SCI needs.

22.3 Surgery, anesthesia, hospitalization, and acute illness

Tell the surgical or anesthesia team about every cannabis product you use. Include the route, THC and CBD amounts, frequency, usual dose, and the date and time of your most recent use. Do not hide cannabis use because you fear judgment. Cannabis may overlap with sedatives, pain medicines, blood pressure changes, or breathing concerns, so accurate information helps the team plan anesthesia, monitoring, and recovery safely. During hospitalization or acute illness, do not use a personal cannabis product without approval from the treating team. Infection, dehydration, breathing difficulty, delirium, new weakness, surgery, and medication changes can alter your response, even when your usual dose was previously manageable.

23. Legal Access, Employment, Travel, and Cost

23.1 Accessing medical cannabis legally

Medical cannabis rules differ by state and may change. Use your state’s official cannabis or health department website to confirm whether SCI or a related symptom qualifies and whether you need clinician certification, registration, renewal, or a designated caregiver. Before purchasing, confirm:

• The possession amount permitted
• The cannabis forms allowed
• Where products may be purchased
• Whether home delivery is permitted
• Whether your registration has an expiration date
• Whether a caregiver must register separately
• Where cannabis use is prohibited

Include all costs when deciding whether a trial is practical. These may include the clinical visit, state registration, renewal, products, transportation, follow-up care, and equipment needed for accurate dosing.

23.2 Employment and drug testing

A medical cannabis authorization does not automatically protect every employee from testing, discipline, or workplace restrictions. Protections vary by state, employer, contract, job duties, and whether your work is regulated under federal safety rules. Ask for the written workplace policy before beginning cannabis, especially if you drive, operate equipment, provide clinical care, carry a weapon, or perform another safety-sensitive task. Federal transportation testing rules may apply independently of your state medical cannabis authorization. A drug test may detect prior cannabis exposure without showing exactly when impairment occurred. Speak with an employment attorney or qualified benefits adviser when your job, disability accommodation, workers’ compensation, or professional license could be affected.

23.3 Travel, housing, and federal restrictions

Do not assume that permission in your home state follows you into another state, tribal jurisdiction, federal property, or foreign country. Confirm the current rules for your departure point, destination, transportation provider, and every place where you will possess or use the product. Federal cannabis policy changed in 2026 for certain FDA-approved and state licensed medical products, but the change did not create unrestricted nationwide possession or recreational legality. Court challenges and additional federal proceedings were still active in July 2026, so patients should verify current rules rather than relying on older guidance. Review your lease, housing program rules, rehabilitation facility policy, and home care agreement before storing or using cannabis. When travel or housing rules do not permit your product, ask your clinician about a temporary symptom plan rather than carrying cannabis into a setting where its legal status is uncertain.

24. Combining Cannabis With Comprehensive SCI Care

24.1 Physical and occupational rehabilitation

Cannabis should support your rehabilitation goals rather than replace therapy. Physical therapy may address strength, movement, flexibility, positioning, endurance, and mobility, while occupational therapy may help with transfers, dressing, bathing, eating, wheelchair skills, and other daily activities. Tell your therapists when you use cannabis and which symptom you are targeting. They can check whether it changes muscle tone, coordination, alertness, pain during movement, transfer technique, or your ability to follow instructions safely. Schedule cannabis carefully around rehabilitation sessions. A dose that reduces pain or spasms may help participation, but excessive dizziness, sleepiness, or intoxication may reduce safety and make it harder to measure your true physical ability.

24.2 Noncannabis pain and spasticity strategies

Neuropathic pain and spasticity usually respond best to a plan that addresses several possible causes. Medicines, stretching, range-of-motion exercises, positioning, pressure relief, equipment adjustments, injections, counseling, and treatment of bladder, bowel, or skin triggers may all remain important. Do not increase cannabis automatically when pain or spasms worsen. A urinary infection, constipation, pressure injury, poor wheelchair fit, tight clothing, missed medicine, or another health problem may be increasing your symptoms and may require direct treatment. Keep the strategies that improve function even when cannabis helps. SCI pain can be difficult to remove completely, so the practical goal may be better sleep, easier care, safer movement, or greater participation rather than the complete absence of discomfort.

24.3 Nutrition, sleep, and general health

Nutrition and hydration affect bowel function, skin health, energy, body weight, and medication tolerance. Follow the fluid, calorie, protein, and fiber guidance provided by your SCI team, especially if you have kidney, bladder, swallowing, or bowel concerns. Cannabis may increase appetite, reduce appetite, cause dry mouth, or make you less aware of meal and fluid routines. Record these changes and choose foods that support your health rather than relying mainly on snacks when THC increases hunger. Protect sleep with a regular schedule, comfortable positioning, pressure relief, and treatment of pain, spasms, breathing problems, and bladder interruptions. Good sleep supports attention, memory, mood, and daily activity, while persistent sleep problems should be discussed with your clinician rather than managed only by increasing cannabis.

25. Tracking Results and Deciding Whether to Continue

25.1 The SCI cannabis treatment diary

A treatment diary shows whether cannabis is producing repeatable benefits. Complete it before taking cannabis and again after the expected effects begin so you can compare symptoms, function, and side effects. Record the same information each time:

• Date and time
• Product name and route
• THC and CBD amounts
• Pain and spasm ratings
• Sleep quality
• Blood pressure symptoms or readings
• Ability to transfer and complete personal care
• Bladder and bowel changes
• Mood, alertness, and concentration
• Unwanted effects

Keep the diary simple enough to complete regularly. Bring it to follow-up appointments so your clinician can identify patterns that may not be clear from memory alone.

25.2 Continue, adjust, or stop

Continue the trial when the selected symptom consistently improves, and the benefit supports daily functioning. Useful changes may include better sleep, fewer painful spasms, easier transfers, improved therapy participation, or less interruption from neuropathic pain. An adjustment may be appropriate when some benefit appears, but the dose, timing, THC amount, CBD amount, or route causes manageable problems. Change one part of the plan at a time so you can tell which adjustment helped. Stop and contact your clinician when cannabis causes repeated confusion, fainting, unsafe transfers, breathing concerns, severe anxiety, worsening function, or no meaningful benefit. Dispensary cannabis has not completed the FDA approval process for treating SCI, so your personal results and safety monitoring remain central to the decision.

25.3 Long-term review

A product that helps during the first month may not remain equally useful over time. Review symptom control, dose changes, tolerance, side effects, costs, medicine interactions, and effects on work, relationships, rehabilitation, and independence. Schedule regular reviews with your care team rather than renewing cannabis use automatically. Reassessment is especially important after surgery, hospitalization, a new prescription, a change in breathing or blood pressure, or a major change in your bladder, bowel, skin, pain, or spasticity. Your long-term plan should continue only as long as the benefits outweigh the risks. CBD and other cannabis products can have side effects, interactions, and uncertain quality, so ongoing use still deserves the same careful review as other active treatments.

26. Patient Experiences, Frequently Asked Questions, and Practical Tools

26.1 Real patient decision scenarios

You have burning pain below your injury level that continues despite prescribed medicine and positioning changes. After discussing interactions with your clinician, you try a measured cannabis dose at night and record pain, sleep, alertness, and morning transfers. You continue only if the improvement is repeatable and your daily function remains safe. Your spasms suddenly become stronger after several stable weeks. Instead of increasing cannabis immediately, you check your catheter, bowel routine, skin, positioning, and general health because infections, constipation, skin problems, and spasticity changes can worsen SCI pain. New symptoms or major changes should be assessed before they are treated as ordinary cannabis tolerance. You become dizzy during a transfer after increasing an edible dose. You stop taking more, remain seated safely, obtain assistance, and review the dose, route, blood pressure, and other medicines with your clinician. A product is not suitable simply because it reduces pain if it also makes essential care or movement unsafe.

26.2 Frequently asked questions

These questions address practical situations not covered elsewhere in this guide. Each answer gives a focused starting point, but your SCI team should personalize recommendations to your health and routines. What should I do if my cannabis product is recalled? Stop using the product and check your state regulator or dispensary notice for batch details. Keep the package, follow return instructions, and report any concerning symptoms to your clinician promptly. How should I dispose of unused or expired cannabis? Keep unused cannabis secured until disposal. Follow your state program or dispensary instructions, remove personal information, and never flush products unless the label or an official authority specifically directs it. What should I do if I miss a planned cannabis dose? Do not automatically double the next dose. Record the missed dose, continue your usual schedule, and ask your clinician how to handle repeated missed doses when timing affects symptom control. Should my personal care attendant know about my cannabis plan? Anyone helping with transfers, medications, bladder care, or emergencies should know enough to ensure your safety. Clearly share the product, dose, timing, expected effects, warning signs, and emergency contact plan. How should I manage cannabis if I use an ostomy? Cannabis does not replace ostomy care or evaluation of reduced output, leakage, swelling, pain, or skin changes. Ask your clinician whether sedation, appetite changes, or dehydration could disrupt your routine. Should I carry medical identification that mentions cannabis use? A medical identification card can help emergency clinicians understand your SCI, autonomic dysreflexia risk, medicines, allergies, and cannabis use. Include only information you are comfortable sharing and update it regularly.

26.3 Downloadable patient tools

The following tools can help you prepare for appointments and run a safer cannabis trial:

• Personal SCI symptom map
• Three-day baseline symptom sheet
• Cannabis dose and response diary
• Current medicine and supplement list
• Product label and testing checklist
• Blood pressure and dizziness record
• Autonomic dysreflexia emergency card
• Bladder, bowel, sleep, and spasm tracker
• Follow-up appointment summary

Your diary should include the date, dose, THC and CBD amounts, route, symptom ratings, functional changes, side effects, and other medicines taken near the same time. MSKTC advises keeping a record of what improves or worsens SCI pain because individual pain patterns differ and may require several treatment approaches. You can keep these tools on paper, in a phone note, or in a spreadsheet, as long as you use them consistently. Bring the records and product label to each review, change only one part of the plan at a time, and seek medical evaluation instead of merely documenting urgent symptoms such as breathing difficulty, new weakness, severe pain, fainting, or signs of autonomic dysreflexia.

Choose DocMJ for Personalized Medical Cannabis Guidance

At DocMJ, we connect patients with compassionate medical marijuana physicians who evaluate eligibility and explain treatment options for spinal cord injury symptoms. We help you understand safe access, dosing considerations, and state requirements. Schedule your consultation today and take the next step toward informed, patient-centered symptom care with confidence.

Citations 

1. Badur, N. B., Winkle, M. J., & Leslie, S. W. (2025, June 2). Autonomic dysreflexia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482434/
2. Busse, J. W., Vankrunkelsven, P., Zeng, L., Heen, A. F., Merglen, A., Campbell, F., Granan, L. P., et al. (2021). Medical cannabis or cannabinoids for chronic pain: A clinical practice guideline. BMJ, 374, n2040. https://doi.org/10.1136/bmj.n2040
3. Filippini, G., Minozzi, S., Borrelli, F., Cinquini, M., & Dwan, K. (2022). Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Database of Systematic Reviews, 2022(5), CD013444. https://doi.org/10.1002/14651858.CD013444.pub2
4. Health Canada. (2024, March 25). Health effects of cannabis. Government of Canada. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/health-effects/effects.html
5. National Institute of Neurological Disorders and Stroke. (2026, March 13). Spinal cord injury. National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/spinal-cord-injury
6. Reyes, M. R., & Chiodo, A. (2023). Spasticity and spinal cord injury. Model Systems Knowledge Translation Center. https://msktc.org/sci/factsheets/spasticity-and-spinal-cord-injury
7. U.S. Food and Drug Administration. (2023, February 24). FDA and cannabis: Research and drug approval process. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process